In a study, an alternative treatment regimen that is less toxic than standard dose-intensive chemotherapy was found to be highly effective for adults with Burkitt lymphoma across all age groups and independent of HIV status.
Researchers at Fox Chase Cancer Center found that breast cancer patients describe having thoughts and feelings that can prevent them from discussing cancer-related sexual issues with their healthcare providers, even if they would like to.
Two Immunoscore clinical studies in stage III colon cancer patients validated the clinical value of Immunoscore to refine patients stratification and predict which patients benefit most from 6 months adjuvant chemotherapy.
In an international trial led by researchers at The University of Texas MD Anderson Cancer Center, treatment with MK-6482, the small molecule inhibitor of hypoxia-inducible factor (HIF)-2a was well tolerated and resulted in clinical responses for patients with von Hippel-Lindau disease–associated renal cell carcinoma.
The Northwell Health Cancer Institute has recruited four experts to its cancer program:
Medical sociologist Pamela Hull was named associate director of population science and community impact at the University of Kentucky Markey Cancer Center
An observational study of more than 3,000 patients hospitalized with COVID-19 at Hackensack Meridian Health has shown that hydroxychloroquine doesn't improve survival for hospitalized patients.
Genentech, a member of the Roche Group, has launched a phase III, randomized, double-blind, multicenter study (REMDACTA) to evaluate the safety and efficacy of Actemra (tocilizumab) plus the investigational antiviral remdesivir, versus placebo plus remdesivir in hospitalized patients with severe COVID-19 pneumonia.
A team of data scientists and cancer doctors from the University of Michigan Rogel Cancer Center and the U-M School of Public Health developed a free, web-based application to compare the long-term risk for a patient whose cancer treatment was postponed.
In a survey conducted by the American Cancer Society Cancer Action Network survey of cancer patients and survivors, 87% of respondents said the COVID-19 pandemic had affected their health care in some manner, up from 51% in an April survey.
